Matinas BioPharma Holdings, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2018

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Matinas BioPharma Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2018.
Matinas BioPharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.41M, a 33.2% increase year-over-year.
Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $3.83M, a 6.56% increase from 2017.
Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2017 was $3.6M, a 137% increase from 2016.
Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2016 was $1.52M, a 4.59% decline from 2015.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2018	$3.83M	+$236K	+6.56%	Jan 1, 2018	Dec 31, 2018	10-K	2019-04-01
2017	$3.6M	+$2.08M	+137%	Jan 1, 2017	Dec 31, 2017	10-K	2019-04-01
2016	$1.52M	-$73K	-4.59%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-16
2015	$1.59M	-$382K	-19.4%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-16
2014	$1.97M	+$1.65M	+506%	Jan 1, 2014	Dec 31, 2014	10-K	2016-03-30
2013	$326K			Jan 1, 2013	Dec 31, 2013	10-K	2015-03-31

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.